Navigation Links
First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer
Date:7/5/2011

AMSTERDAM, July 5, 2011 /PRNewswire/ -- Oncimmune® LLC, maker of EarlyCDT™-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, today announces that an abstract (P4.013) "EarlyCDT-Lung test: audit of 1,000 patients in clinical practice" supports the previously published validation studies on EarlyCDT-Lung with sensitivity for non-small cell lung cancer (NSCLC) at least as high as in the validation studies, including early stage disease. Leading lung cancer expert, James Jett, M.D., National Jewish Health, presents these findings Thursday, July 7, 2011, from 10:00 a.m. - 12:30 p.m. at Exhibition Hall, Amsterdam Rai, The Netherlands.  The complete abstract can be accessed and viewed on the IASLC World Conference on Lung Cancer web site at http://www.2011worldlungcancer.org/abstracts.html.

"The EarlyCDT-Lung test is a new technology with the potential to shift our ability to diagnose lung cancer earlier than is currently achieved," said James Jett, M.D., Professor of Medicine, National Jewish Health.  "Data auditing the use of the test in clinical practice are consistent with the case-controlled studies. These data indicate that the EarlyCDT-Lung test can risk stratify normal versus malignant nodules.  The current guidelines that pulmonologists use for risk stratification and guiding the monitoring of CT nodules (Fleischner guidelines) a
'/>"/>

SOURCE Oncimmune (USA) LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015  Cipla, a global pharmaceutical company which ... of all patients, today announced that its UK arm, ... two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals ... is valued at $550 million and will be an ... is over $200 million for the year ended Dec ...
(Date:9/3/2015)... 3, 2015 Report Details ... Drugs, Industry Changes and Emerging Opportunities What,s the ... Visiongain,s new study forecasts those pharmaceutical revenues. There ... industry. You also explore trends, results, treatments, R&D, ... gives revenue predictions to 2025 at overall world ...
(Date:9/3/2015)... -- Report Details What can be expected ... to grow at the fastest rates? Visiongain,s brand new ... trends, opportunities and prospects there. Our 205-page ... most lucrative areas in the industry and the future ... sales at overall world market and regional level. You ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... Inc. (NASDAQ: MSON ), a medical ... therapeutic ultrasonic products worldwide for wound debridement, spinal ... surgical and medical applications, has announced its immediate ... SonicOne® technology to the BoneScalpel™ surgical platform.  The ...
... Simbionix USA Corporation, the world,s leading ... medical professionals and the healthcare industry, is pleased to ... UK for its innovative PROcedure Rehearsal Studio ™ . ... a first in industry product, allowing clinicians to create patient ...
Cached Medicine Technology:Misonix Announces Entry Into Surgical Wound Debridement 2Misonix Announces Entry Into Surgical Wound Debridement 3Patent Granted for Simbionix Procedure Rehearsal Studio™ 2
(Date:9/4/2015)... ... September 04, 2015 , ... ... assistance company today announced that it has entered into a multi-year agreement with ... an agreement to bridge the link between American healthcare, Jamaican healthcare and Health ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Allied Anesthesia is ... innovative medicine is the norm not the exception. , St. Jude was recently named ... Heart Association/American Stroke Association, making it one of only 10 hospitals in the state ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... partner for the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in ... of Tieraona Low Dog, MD, an internationally renowned educator, physician and thought leader ...
(Date:9/3/2015)... ... September 03, 2015 , ... Topical BioMedics, Inc., hosted ... of his six-month, 10,000 mile journey from Santiago, Chile to Times Square and ... the “Connecting Las Americas” project—Max crossed six countries in 168 days on his ...
(Date:9/3/2015)... ... 03, 2015 , ... Real Time Pain Relief (RTPR), makers of ... David Mason has signed an official endorsement deal with the company. Originally from New ... his first bull at 15. He is an Australian bull riding champion, following in ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3
... far northern South Africa turn to nature when seeking to ... emerged in news reports//. ,The root of the wild ... Venda district near the Kruger National Park along the border ... ,The compound extracted from its root and consumed with tea ...
... cheap anti-malarial was found effective in treating malaria in ... BBVA, and Pedro Alonso, coordinator of the Centre of ... of their study are to be published in the ... ,This work, that will be published in the ...
... government's AIDS Control Committee said the BSP, a flagship unit of ... west of Raipur// , has 92 confirmed AIDS patients out of ... the report with 92 confirmed cases followed by Durg with 55 ... AIDS Control Committee. ,Raipur stands fifth in the tally ...
... the changes associated with it begin at vessel branches ... those branches which activate// a cellular protein that has ... first to link mechanical forces with structural and biochemical ... atherosclerotic lesions form preferentially at branches of coronary arteries. ...
... of London, are developing new drugs that are designed ... harmless//. ,Professor David Garrod said the research – ... Project of the Year – takes a completely new ... ,"The technology is based on our earlier discovery ...
... by secondhand smoke. Another reason that passive smoking hurts ... during minor surgeries. ,Dwight Jones, MD, of ... and Women's Hospital followed 405 children, 168 of whom ... day surgical procedures at Children's, ranging from drainage of ...
Cached Medicine News:Health News:Intermittent Treatment Found Effective In Malaria 2Health News:Intermittent Treatment Found Effective In Malaria 3Health News:Intermittent Treatment Found Effective In Malaria 4Health News:Intermittent Treatment Found Effective In Malaria 5Health News:AIDS shadow looms over Bhilai plant 2Health News:Atherosclerosis and its Mechanics 2Health News:Atherosclerosis and its Mechanics 3Health News:Scientist Confident of Combating Allergy in Five Years 2Health News:Children Most Affected By Second Hand Smoke 2
Micro-slide cabinet space saving design, stores as many as 54,000 slides in only two square feet of floor space. Cabinets and base come in 3 colors....
Fisherbrand* Micro Slide Storage Cabinets and Bases (New), available in dark beige, tan, green, or white. Optional bases available with or without legs....
Space-saving storage cabinets for microscope slides....
Seasoned oak cabinet with flat sides and disappearing door...
Medicine Products: